Latest Articles

Publication Date
FROM THE LABS: A potentially simpler test and novel therapy for endometriosis - Baylor College of Medicine | BCM

FROM THE LABS: A potentially simpler test and novel therapy for endometriosis Baylor College of Medicine | BCM

Published: Oct. 15, 2024, 3 p.m.
A potentially simpler test and novel therapy for endometriosis - Baylor College of Medicine | BCM

A potentially simpler test and novel therapy for endometriosis Baylor College of Medicine | BCM

Published: Oct. 15, 2024, 3 p.m.
A potentially simpler test and novel therapy for endometriosis - blogs.bcm.edu

A potentially simpler test and novel therapy for endometriosis blogs.bcm.edu

Published: Oct. 15, 2024, 3 p.m.
Inhibiting NTRK2 signaling causes endometriotic lesion regression.

Endometriosis is a common gynecological disease in reproductive-age women. Although the hormone-dependent therapy is the first line treatment for endometriosis, it is not a curative regimen and associated with severe …

Published: Oct. 14, 2024, 1:21 p.m.
Progestin-based pharmacotherapy in fertility preservation in early endometrial cancer:A Minireview - Frontiers

Progestin-based pharmacotherapy in fertility preservation in early endometrial cancer:A Minireview Frontiers

Published: Oct. 14, 2024, 11:09 a.m.
Resveratrol and Its Natural Analogs Mitigate Immune Dysregulation and Oxidative Imbalance in the Endometriosis Niche Simulated in a Co-Culture System of Endometriotic Cells and Macrophages.

Background: Inflammation and immune cell dysfunction are critical facilitators of endometriosis pathophysiology. Macrophages are renowned for stimulating lesion growth, vascularization, innervation, and pain generation. By combining macrophages and endometriotic cells, …

Published: Oct. 14, 2024, midnight
Clear Cell Carcinoma Arising From Adenomyotic Cyst: A Case Report.

Clear cell carcinoma often arises from endometriosis, primarily from ovarian chocolate cysts and much less frequently from adenomyosis. We herein report a case of clear cell carcinoma arising from adenomyotic …

Published: Oct. 14, 2024, midnight
Preventing recurrence of endometriosis-related pain by means of long-acting progestogen therapy: the PRE-EMPT RCT.

Endometriosis affects 1 in 10 women, many of whom have surgery for persistent pain. Recurrence of symptoms following an operation is common. Although hormonal treatment can reduce this risk, there …

Published: Oct. 13, 2024, 8:56 p.m.
[Summarising the efficiency of psychological interventions in the treatment of endometriosis].

Endometriosis is a common gynecological disease affecting 5-10% of women resulting in several psychological impacts. Regarding the high prevalence as well as extensive somatic symptoms, this has become a growing …

Published: Oct. 13, 2024, 4:35 p.m.
Effects of pretreatment with long-acting gonadotropin-releasing hormone agonists on pregnancy outcomes in patients with minimal and mild peritoneal endometriosis: A retrospective study of 274 frozen-thawed embryo transfer cycles.

To investigate the effects of pretreatment with long-acting gonadotropin-releasing hormone agonist (GnRH-a) before frozen-thawed embryo transfer (FET) on pregnancy outcomes in patients after minimal-mild (stages I-II) peritoneal endometriosis surgery. A …

Published: Oct. 13, 2024, 4:32 p.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!